Calimbang, Jurelyn M.
HRN: 16-80-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2026
CEFTRIAXONE 1G (VIAL)
06/24/2026
07/01/2026
IV
1g
Q12
T/c Sepsis
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines